AbCellera Biologics Inc. ABCL Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $75.13M+161% | $28.83M-24.2% | $38.03M-92.2% | $485.43M+29.4% | ||
| $186.83M+11.7% | $167.26M-4.8% | $175.66M+62.8% | $107.88M+73.8% | ||
| —— | —— | —— | —— | ||
| $292.23M-14.9% | $343.6M+24.8% | $275.23M+2.3% | $268.92M+57.5% | ||
| -$217.11M+31.0% | -$314.77M-32.7% | -$237.21M— | —— | ||
| -289%+803pp | -1,091.6%-468pp | -623.8%— | —— | ||
| $39.51M-65.5% | $114.37M+81.0% | $63.18M+180% | $22.59M+54.1% | ||
| -$177.6M+11.4% | -$200.4M-15.1% | -$174.03M— | —— | ||
| -$31.18M+16.9% | -$37.54M-35.8% | -$27.63M-134% | $82.1M+25.0% | ||
| -$146.41M+10.1% | -$162.86M-11.2% | -$146.4M— | —— | ||
| -194.9%+370pp | -564.8%-180pp | -385%— | —— | ||
| -$0.49+10.9% | -$0.55-5.8% | -$0.52— | —— | ||
| -$194.97M+16.8% | -$234.38M-10.1% | -$212.81M— | —— | ||
| -259.5%+553pp | -812.9%-253pp | -559.6%— | —— | ||
| -$217.11M+31.0% | -$314.77M-32.7% | -$237.21M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does AbCellera Biologics Inc.'s income statement data come from?
- Every line is extracted from AbCellera Biologics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.